<?xml version="1.0" encoding="UTF-8"?>



<records>

  <record>
    <language>eng</language>
          <publisher>Oriental Scientific Publishing Company</publisher>
        <journalTitle>Biomedical and Pharmacology Journal</journalTitle>
          <issn>0974-6242</issn>
            <publicationDate>2021-03-30</publicationDate>
    
        <volume>14</volume>
        <issue>1</issue>

 
    <startPage>303</startPage>
    <endPage>309</endPage>

	 
      <doi>10.13005/bpj/2126</doi>
        <publisherRecordId>37021</publisherRecordId>
    <documentType>article</documentType>
    <title language="eng">Influence of Supplementary Vitamin D on the Prognostic Pathway of Type1 Diabetes Among Children</title>

    <authors>
	 


      <author>
       <name>Mostafa Hassan Ragab </name>

 
		
	<affiliationId>1</affiliationId>
      </author>
    

	 


      <author>
       <name>Eman Monir Sherif</name>


		
	<affiliationId>2</affiliationId>

      </author>
    

	 


      <author>
       <name>Nadia Badawy Abd- El Gawad</name>

		
	<affiliationId>3</affiliationId>
      </author>
    

	 


      <author>
       <name>Safaa Mohamed Elserougy</name>

		
	<affiliationId>3</affiliationId>
      </author>
    


	 


      <author>
       <name>Eman Essam Shaban</name>

		
	<affiliationId>4</affiliationId>
      </author>
    


	 


      <author>
       <name>Elham Mohamed Mostafa </name>

		
	<affiliationId>4</affiliationId>
      </author>
    
    </authors>
    
	    <affiliationsList>
	    
		

		
		
		
		
		
	  </affiliationsList>






    <abstract language="eng">Diabetes is one of the commonest chronic diseases worldwide. Vitamin D deficiency showed to be increasing, and have a potential role in autoimmune diseases among which in type 1 diabetes. The aim The aim of the study was to assess the impact of oral vitamin D supplementation on blood glucose (HbA1C) in T1DM patients and to find out the role of vitamin D as a biomarker for follow of T1DM patients compared to HbA1C. Subjects and methods: A randomized interventional clinical study was designed. The study enrolled 60 children patients with T1DM. Only 45 children continued to the end of study. Initial (pre-intake) assessment included history taking, clinical examination, and measurement of serum 25-OH vitamin D3 and serum HbA1C. These children received oral vitamin D supplements for 3 months then post-intake assessment were done again. Results: The study showed that serum vitamin D was deficient among Egyptian children and adolescents with T1DM (mean 11.4±3.4 ng/ml). , 53.33% of the patients had vitamin D deficiency with a 35.6% had insufficiency and 11.11% were VD sufficient.   Patients received oral vitamin D supplementation for 3 months after which marked improvement in the levels of serum vitamin D levels and HA1C, 87.5% and 86.5% respectively.</abstract>

    <fullTextUrl format="html">https://biomedpharmajournal.org/vol14no1/influence-of-supplementary-vitamin-d-on-the-prognostic-pathway-of-type1-diabetes-among-children/</fullTextUrl>

<keywords language="eng">

      
        <keyword>Diabetes - Type1 diabetes mellitus (T1DM) -Vitamin D -Ultra-Violet Index</keyword>
      
</keywords>
  </record>
</records>